AR-12463

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAR-12463
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane receptors antagonistsCholesterol synthesis inhibitors
TargetsThromboxane receptors
Therapy Area/IndicationsThrombosisAtherosclerosisMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUcb
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb
Active IndicationsN/A
Inactive IndicationsThrombosisAtherosclerosisMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A